{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:55:57Z","timestamp":1791381357575,"version":"4.3.3"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","award":["ATLAS19-M2-101"],"award-info":[{"award-number":["ATLAS19-M2-101"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ijantimicag.2023.106724","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T05:40:10Z","timestamp":1673588410000},"page":"106724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Multidrug-resistant Gram-negative bacilli recovered from respiratory and blood specimens from adults: the ATLAS surveillance program in European hospitals, 2018\u20132020"],"prefix":"10.1016","volume":"61","author":[{"given":"Romney M.","family":"Humphries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana H.","family":"Hey-Hadavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3339-2701","authenticated-orcid":false,"given":"Meredith","family":"Hackel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2023.106724_bib0001","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2147\/CIA.S133640","article-title":"Review of antimicrobial use and considerations in the elderly population","volume":"13","author":"Giarratano","year":"2018","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0002","unstructured":"Borsch-Supan A. Survey of Health, Ageing and Retirement in Europe (SHARE), Wave 8. SHARE-ERIC. Release version 1.0.0. Data set 2021."},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0003","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12931-018-0781-4","article-title":"Trends in mortality from pneumonia in the Europe union: a temporal analysis of the European Detailed Mortality Database between 2001 and 2014","volume":"19","author":"Marshall","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0004","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13613-018-0430-6","article-title":"Ten-year trends in intensive care admissions for respiratory infections in the elderly","volume":"8","author":"Laporte","year":"2018","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0005","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s13054-020-03100-4","article-title":"Long-term survival of elderly patients after intensive care unit admission for acute respiratory infection: a population-based, propensity score-matched cohort study","volume":"24","author":"Guillon","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0006","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/jgs.12544","article-title":"Critically ill elderly adults with infection: analysis of the Extended Prevalence of Infection in Intensive Care study","volume":"61","author":"Dimopoulos","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0007","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.ccm.0000435665.07446.50","article-title":"Prevalence, risk factors, and mortality for ventilator-associated pneumonia in middle-aged, old, and very old critically ill patients","volume":"42","author":"Blot","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0008","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s100960050241","article-title":"Association between institutionalization and carriage of multiresistant bacteria in the elderly at the time of admission to a general hospital","volume":"18","author":"Eveillard","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0009","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.46.1800100","article-title":"Antimicrobial prescribing in long-term care facilities: a nationwide point-prevalence study, Slovenia, 2016","volume":"23","author":"Stepan","year":"2018","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0010","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/antibiotics10060680","article-title":"Prevalence and risk factors for multidrug-resistant organisms colonization in long-term care facilities around the world: a review","volume":"10","author":"Rodriguez-Villodres","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0011","series-title":"Point prevalence survey of healthcare-associated infections and antimicrobial use in European long-term care facilities. April\u2013May 2013","year":"2014"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0012","series-title":"Trends in severe disability among elderly people: assessing the evidence in 12 OECD countries and the future implications. OECD Health Working Paper No. 26","author":"Lafortune","year":"2007"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0013","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s41999-020-00347-6","article-title":"COVID-19 highlights the need for universal adoption of standards of medical care for physicians in nursing homes in Europe","volume":"11","author":"O'Neill","year":"2020","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0014","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.archger.2012.05.006","article-title":"Increased multi-drug resistance among the elderly on admission to the hospital\u2014a 12-year surveillance study","volume":"56","author":"Denkinger","year":"2013","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0924-8579(02)00204-2","article-title":"Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America: SENTRY Antimicrobial Surveillance Program, 1997\u20132000","volume":"20","author":"Diekema","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0016","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/jac\/dkp349","article-title":"Prevalence of antimicrobial-resistant bacteria isolated from older versus younger hospitalized adults: results of a two-centre study","volume":"64","author":"Weber","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0017","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1128\/JCM.01588-06","article-title":"Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp","volume":"45","author":"Jones","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0018","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1128\/AAC.05186-14","article-title":"Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013","volume":"59","author":"Lob","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0019","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1128\/AAC.00220-16","article-title":"In vitro susceptibility of global surveillance isolates of Pseudomonas aeruginosa to ceftazidime\u2013avibactam (INFORM 2012 to 2014)","volume":"60","author":"Nichols","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0020","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1093\/cid\/ciaa1478","volume":"72","author":"Tamma","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0021","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.idc.2017.07.015","article-title":"Bacterial pneumonia in older adults","volume":"31","author":"Henig","year":"2017","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0022","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1164\/ajrccm.163.3.2005075","article-title":"Etiology of severe pneumonia in the very elderly","volume":"163","author":"El-Solh","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0023","first-page":"e01717","article-title":"A systematic review and meta-analyses of the clinical epidemiology of carbapenem-resistant Enterobacteriaceae","volume":"62","author":"van Loon","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0024","series-title":"Carbapenem-resistant Enterobacteriaceae, second update \u201326 September 2019","year":"2019"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0025","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1186\/s12879-021-06153-0","article-title":"In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime\u2013avibactam and comparators (2016\u20132018)","volume":"21","author":"Pierard","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0026","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1128\/AAC.00897-16","article-title":"Interaction of avibactam with class B metallo-\u03b2-lactamases","volume":"60","author":"Abboud","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0027","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jac\/dkz456","article-title":"In vitro activity of ceftazidime\/avibactam against isolates of carbapenem-non-susceptible Enterobacteriaceae collected during the INFORM global surveillance programme (2015\u201317)","volume":"75","author":"Spiliopoulou","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0028","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0029","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1378\/chest.10-0463","article-title":"Steady-state pharmacokinetics and BAL concentration of colistin in critically ill patients after IV colistin methanesulfonate administration","volume":"138","author":"Imberti","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0030","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1128\/AAC.00881-09","article-title":"Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model","volume":"54","author":"Bulitta","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0031","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1128\/AAC.06380-11","article-title":"Impact of two-component regulatory systems PhoP\u2013PhoQ and PmrA\u2013PmrB on colistin pharmacodynamics in Pseudomonas aeruginosa","volume":"56","author":"Ly","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0032","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1128\/AAC.02831-15","article-title":"Paradoxical effect of polymyxin B: high drug exposure amplifies resistance in Acinetobacter baumannii","volume":"60","author":"Tsuji","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0033","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"Torres","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0034","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0035","series-title":"Guidance document: EUCAST breakpoints in brackets","year":"2021"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0036","series-title":"Surveillance of antimicrobial resistance in Europe 2018. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)","year":"2019"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0037","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.45.2001735","article-title":"Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019","volume":"25","author":"Lotsch","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0038","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/cid\/ciab696","article-title":"Mortality, length of stay, and healthcare costs associated with multidrug-resistant bacterial infections among elderly hospitalized patients in the United States","volume":"74","author":"Nelson","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0039","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3349\/ymj.2012.53.5.974","article-title":"Clinical outcomes of tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii infection","volume":"53","author":"Shin","year":"2012","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13054-017-1916-6","article-title":"Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis","volume":"21","author":"Jung","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0041","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cmi.2021.05.002","article-title":"Clinical management of severe infections caused by carbapenem-resistant Gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations","volume":"28","author":"Carrara","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106724_bib0042","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/phar.2449","article-title":"Approach to the treatment of patients with serious multidrug-resistant Pseudomonas aeruginosa iinfections","volume":"40","author":"O'Donnell","year":"2020","journal-title":"Pharmacotherapy"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923000146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923000146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:44:24Z","timestamp":1760377464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857923000146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0924857923000146"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106724","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidrug-resistant Gram-negative bacilli recovered from respiratory and blood specimens from adults: the ATLAS surveillance program in European hospitals, 2018\u20132020","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106724","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106724"}}